Quarterly Results

  • Company Name :
Rubicon Research Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 544578
  • NSE Symbol:
  • RUBICON
  • P/E(TTM):
  • 81.19
  • ISIN Demat:
  • INE506V01022
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 9.62
  • Book Value(₹):
  • 76.31
  • Market Cap(₹Cr.):
  • 12,867.82
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 301.71 336.47 278.03
Excise Duty 0.00 0.00 0.00
Net Sales 301.71 336.47 278.03
Other Operating Income 0.00 0.00 0.00
Other Income 4.30 1.51 1.44
Total Income 306.01 337.98 279.46
Total Expenditure 239.46 257.37 214.89
PBIDT 66.55 80.61 64.58
Interest 7.51 9.21 8.85
PBDT 59.04 71.41 55.73
Depreciation 9.51 9.78 8.30
Tax 10.12 19.12 10.05
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 2.23 -3.30 2.23
Reported Profit After Tax 37.18 45.81 35.15
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 37.18 45.81 35.15
EPS (Unit Curr.) 2.28 2.97 2.28
EPS (Adj) (Unit Curr.) 2.28 2.97 2.28
Calculated EPS (Unit Curr.) 2.26 2.97 2.28
Calculated EPS (Adj) (Unit Curr.) 2.26 2.97 2.28
Calculated EPS (Ann.) (Unit Curr.) 9.03 11.87 9.12
Calculated EPS (Adj) (Ann.) (Unit Curr.) 9.03 11.87 9.12
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 16.48 15.44 15.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 22.06 23.96 23.23
PBDTM(%) 19.57 21.22 20.04
PATM(%) 12.32 13.61 12.64